Travere Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sale | 865 | $18.94 | $16,383 | 73,730 | Jan 22, 2025 |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sale | 925 | $18.94 | $17,520 | 54,002 | Jan 22, 2025 |
| Inrig Jula | CHIEF MEDICAL OFFICER | Sale | 2,066 | $19.10 | $39,461 | 59,883 | Jan 6, 2025 |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sale | 15,000 | $17.22 | $258,300 | 54,927 | Dec 26, 2024 |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sale | 12,090 | $18.30 | $221,247 | 54,927 | Nov 25, 2024 |
| LYONS GARY A | — | Sale | 21,179 | $14.35 | $303,919 | 69,821 | Oct 4, 2024 |
| Meckler Jeffrey A | — | Option Exercise | 40,000 | $10.48 | $419,200 | 121,000 | Sep 30, 2024 |
| Inrig Jula | CHIEF MEDICAL OFFICER | Sale | 684 | $12.98 | $8,878 | 61,949 | Sep 10, 2024 |
| ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | Award / Grant | 6,750 | — | — | 88,842 | Sep 9, 2024 |
| REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | Award / Grant | 6,750 | — | — | 83,020 | Sep 9, 2024 |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | Award / Grant | 6,750 | — | — | 77,085 | Sep 9, 2024 |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | Sale | 21,125 | $11.52 | $243,360 | 361,975 | Sep 5, 2024 |
| Inrig Jula | CHIEF MEDICAL OFFICER | Sale | 2,191 | $11.52 | $25,240 | 62,633 | Sep 5, 2024 |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | Sale | 2,191 | $11.52 | $25,240 | 107,958 | Sep 5, 2024 |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sale | 514 | $9.51 | $4,888 | 70,335 | Sep 4, 2024 |
| Williams Brinkley Ruth | — | Award / Grant | 6,500 | — | — | 19,250 | May 8, 2024 |
| Squarer Ron | — | Award / Grant | 6,500 | — | — | 28,875 | May 8, 2024 |
| Poole Sandra | — | Award / Grant | 6,500 | — | — | 23,500 | May 8, 2024 |
| Orwin John A | — | Award / Grant | 6,500 | — | — | 28,875 | May 8, 2024 |
| Meckler Jeffrey A | — | Award / Grant | 6,500 | — | — | 81,000 | May 8, 2024 |
| LYONS GARY A | — | Award / Grant | 6,500 | — | — | 51,000 | May 8, 2024 |
| COUGHLIN TIMOTHY | — | Award / Grant | 6,500 | — | — | 49,000 | May 8, 2024 |
| Bruhn Suzanne Louise | — | Award / Grant | 6,500 | — | — | 22,250 | May 8, 2024 |
| Baynes Roy D. | — | Award / Grant | 6,500 | — | — | 31,000 | May 8, 2024 |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sale | 54 | $6.74 | $364 | 70,849 | Apr 11, 2024 |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | Award / Grant | 25,000 | — | — | 74,721 | Feb 1, 2024 |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | Sale | 9,106 | $8.53 | $77,674 | 360,616 | Jan 31, 2024 |
| ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | Sale | 2,174 | $8.53 | $18,544 | 83,310 | Jan 31, 2024 |
| REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | Sale | 2,174 | $8.53 | $18,544 | 78,860 | Jan 31, 2024 |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | Sale | 4,195 | $8.53 | $35,783 | 99,503 | Jan 31, 2024 |
| Inrig Jula | CHIEF MEDICAL OFFICER | Sale | 2,174 | $8.53 | $18,544 | 58,074 | Jan 31, 2024 |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Award / Grant | 1,000 | — | — | 54,837 | Jan 31, 2024 |
| REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | Sale | 2,062 | $8.96 | $18,476 | 56,034 | Jan 23, 2024 |
| ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | Sale | 2,062 | $8.96 | $18,476 | 60,484 | Jan 23, 2024 |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | Sale | 7,873 | $8.96 | $70,542 | 234,722 | Jan 23, 2024 |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | Sale | 1,559 | $9.07 | $14,140 | 78,698 | Jan 23, 2024 |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sale | 853 | $9.07 | $7,737 | 49,721 | Jan 23, 2024 |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sale | 910 | $9.07 | $8,254 | 41,337 | Jan 23, 2024 |
| Inrig Jula | Chief Medical Officer | Sale | 2,069 | $9.48 | $19,614 | 35,688 | Jan 4, 2024 |
| Heerma Peter | Chief Commercial Officer | Sale | 3,091 | $8.25 | $25,501 | 80,257 | Oct 3, 2023 |
| Cline Christopher R. | Chief Financial Officer | Sale | 457 | $14.71 | $6,722 | 50,574 | Sep 5, 2023 |
| Dube Eric M | Chief Executive Officer | Award / Grant | 9,900 | — | — | 247,050 | Sep 5, 2023 |
| ROTE WILLIAM E. | Senior Vice President, R&D | Sale | 1,815 | $14.71 | $26,699 | 61,173 | Aug 31, 2023 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | Sale | 1,815 | $14.71 | $26,699 | 58,096 | Aug 31, 2023 |
| Baynes Roy D. | — | Award / Grant | 4,500 | — | — | 24,500 | May 17, 2023 |
| Poole Sandra | — | Award / Grant | 4,500 | — | — | 17,000 | May 17, 2023 |
| Williams Brinkley Ruth | — | Award / Grant | 4,500 | — | — | 12,750 | May 17, 2023 |
| Meckler Jeffrey A | — | Award / Grant | 4,500 | — | — | 74,500 | May 17, 2023 |
| LYONS GARY A | — | Award / Grant | 4,500 | — | — | 44,500 | May 17, 2023 |
| COUGHLIN TIMOTHY | — | Award / Grant | 4,500 | — | — | 42,500 | May 17, 2023 |